Radiation Oncology · Acibadem Altunizade Hospital, İstanbul Prof. Mehmet Ufuk Abacıoğlu, MD
✓ Medically verified profileProf. Mehmet Ufuk Abacıoğlu, MD
Prof. Mehmet Ufuk Abacıoğlu, MD is a radiation oncologist at Acibadem Altunizade Hospital and Acibadem Atasehir Hospital in İstanbul, Turkey. His areas of expertise include radiotherapy and brachytherapy for brain tumors, head and neck cancers, breast cancer and gastrointestinal cancers. He consults in Turkish and English, and video consultations are available for international patients.
Accepting international patientsAbout Prof. Mehmet Ufuk Abacıoğlu, MD
Prof. Mehmet Ufuk Abacıoğlu, MD is a radiation oncologist who practices in the Radiation Oncology units of Acibadem Altunizade Hospital and Acibadem Atasehir Hospital in İstanbul. He has more than 33 years in medicine. He graduated from İstanbul University İstanbul Faculty of Medicine in 1993 and completed his specialty training in Radiation Oncology (Radyasyon Onkolojisi) at the same faculty in 1997. He speaks Turkish and English.
Between 1993 and 1997, Dr. Abacıoğlu worked in the Department of Radiation Oncology at İstanbul Cerrahpaşa Faculty of Medicine. From 1998 to 2011 he served as Professor of Radiation Oncology in the Department of Radiation Oncology at Marmara University Faculty of Medicine, and in 2010 he also held a position as professor of radiation oncology at Neolife Medical Center. He joined Acıbadem Healthcare Services in 2017. His professional roles include Board member and General Secretary of the Turkish Radiation Oncology Association (2009–2010) and Board member (2011–2012), Chair of the Turkish Oncology Group TOG-Central Nervous System Study Group (2007–2010), Executive Board member of the European Association of Neurooncology (EANO) (2010–2014), and Board member and Vice President (2013–2015) and President (2015) of the Neurooncology Association. He is a member of the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the European Society for Therapeutic Radiology and Oncology (ESTRO), the European Organization for Research and Treatment of Cancer (EORTC) Radiation Oncology Group, the Rare Cancer Network and the Türk Akciğer Kanseri Association (TAKD), and he received honorary membership of the Romanian Urology Association in June 2015.
Clinical focus
Dr. Abacıoğlu’s clinical work centers on radiotherapy for cancer. His areas of expertise include brain tumors, head and neck cancers, breast cancer and gastrointestinal oncology. In addition to external beam radiotherapy, he works with brachytherapy, in which a radiation source is placed close to or within the treated tissue.
His published work reflects a particular interest in neuro-oncology. Topics include a dosimetric analysis of radiation-induced hypothyroidism in patients who received radiotherapy to the neck, a treatment planning comparison of RapidArc radiosurgery and GammaKnife for benign brain lesions, whole brain reirradiation in patients with multiple brain metastases, prophylactic cranial irradiation in stage III non-small cell lung cancer, concurrent chemoradiotherapy in muscle-invasive bladder cancer, and health-related quality of life during postoperative chemoradiotherapy in rectal cancer. He has also published interviews with investigators of clinical trials in glioblastoma, primary central nervous system lymphoma and glioma for the Eur Assoc Neurooncol Mag.
How Dr. Abacıoğlu works with international patients
Dr. Abacıoğlu consults in Turkish and English, and interpreters can be arranged for other languages. Before a visit, the international patient team coordinates the collection of prior reports and imaging, such as MRI, CT, X-ray or ultrasound reports, laboratory and pathology results, operative notes and discharge summaries, and arranges appointments and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the options, including whether and how radiotherapy may fit into the overall treatment plan. Video consultations are available for international patients who wish to discuss their case before traveling.
What Dr. Abacıoğlu treats and performs
Each item opens the condition or treatment page with the care pathway for international patients.
Areas of practiceGastrointestinal oncology
Conditions treated
Education, career and memberships
Education & training
Education
- 1997İstanbul University İstanbul Faculty of Medicine Radyasyon Onkolojisi
- 1993İstanbul University İstanbul Faculty of Medicine
Career
Professional Experience
- 2017Acıbadem Healthcare Services
- 2010Neolife Medical Center / Radyasyon Onkolojisi Professorü
- 1998–2011Marmara University Faculty of Medicine / Professor of Radiation Oncology / Department of Radiation Oncology
- 1993–1997İstanbul Cerrahpaşa Faculty of Medicine / Professor of Radiation Oncology / Department of Radiation Oncology
Memberships
Professional Memberships
- Turkish Radiation Oncology Association Board member-General Secretary 2009-2010, Board member 2011-2012
- European Organization for Research and Treatment of Cancer (EORTC) Radiation Oncology Group
- Turkish Oncology Group TOG-Central Nervous System Study Group Chair 2007-2010
- American Society for Radiation Oncology (ASTRO)
- Türk Akciğer Kanseri Association (TAKD)
- American Society of Clinical Oncology (ASCO)
- European Association of Neurooncology (EANO) Board-Executive Board member 2010-2014
- Neurooncology Association Board member-Vice President 2013-2015, President 2015
- Rare Cancer Network
- European Society for Therapeutic Radiology and Oncology (ESTRO)
- Romanian Urology Association Honorary membership (June 2015)
Selected publications
Selected Publications
- Heidelberg University Hospital, about the Phase-ll Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Primary Glioblastoma (CLEOPATRA) Eur Assoc Neurooncol Mag, 4(1): 47-48, (2014) Abacioglu U. Interview with Dr Stephanie E Combs
- V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck Radiai Oncol, 2014; 9:104 Akgun Z, Atasoy BM, Özen Z, Yavuz D, Gulluoglu B, Sengoz M, Abacioglu U
- Critical appraisal of RapidArc radiosurgery with flattening filter free photon beams for benign brain lesions in comparison to GammaKnife: a treatment planning study Radiai Oncol, 2014; 9:119. Abacioglu U, Ozen Z, Yilmaz M, Arifoglu A, Gunhan B, Kayalilar N, Peker S, Sengoz M, Gurdalli S, Cozzi L
- MSKCC, about the RTOG 1114-Phase II randomized Study of Chemotherapy with and without Low-Dose WBRT for Primary Central Nervous Lymphoma Eur Assoc Neurooncol Mag, 4(3): 130-131, (2014). Abacioglu U. Interview with Dr. Antonio Omuro
- MD, VU University Medical Center, Amsterdam, about the Randomized Trial on Internet-Based Treatment of Depressive Symptoms in Glioma Patients Eur Assoc Neurooncol Mag, 4(2): 90-91, (2014) Abacioglu U. Interview with Florien Boele, MSc, and Martin Klein
- Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients Clin Transl Oncol, 16(1): 91-5, (2014) Atasoy BM, Dane F, Alsari Cetin I, Ozgen Z, Ucuncu Kefeli A, Ibrahimov R, Turhal NS, Abacioglu U, Turkeri L
- Who may benefit from prophylactic cranial irradiation amongst stage III non-small cell lung cancer patients? J BUON. 2013;18(2):453-8 Alsan Cetin I, Akgun Z, Atasoy BM, Fulden Yumuk P, Abacioglu U
- The benefit of whole brain reirradiation in patients with multiple brain métastasés Radiai Oncol, 2013; 8(1): 186 Özgen Z, Atasoy BM, Ucuncu Kefeli A, Seker A, Dane F, Abacioglu U
- The effect of magnesium and vitamin E pre-treatments on irradiation-induced oxidative injury of cardiac and pulmonary tissues in rats: a randomized experimental study Anadolu Kardiyol Derg, 12(6), SOS- 14, (2012) 40. Atasoy BM, Ozgen Z, Bostanci K, Yiiksel M, Ozen Z, Ibrahimov R, Abacioglu U
- Flealth-Related Quality of Life During Postoperative Chemoradiotherapy with Oral Uracil-Tegafur and Leucovorin in Rectal Cancer Patients Hepatogastroenterology. Nov 16;60(123). (2012 42. Ozgen Z, Ozden S, Dane F, Atasoy BM, Akgun Z, Yumuk PF, Mayadagli A, Turhal NS, Abacioglu U
